Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T19:57:49.297Z.
Calculation as of: 2026-10-06T19:57:49.297Z.
Quote observation: 2026-10-06T19:55:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c401c00e52a09452fdcb188d3872e1091efc1230c6c65f2aa9c0ebb48d3df0bd
PEG RATIO
N/A
Market Cap
$234.98M
PEG Ratio
6.56
TTM Avg
83.47
3Y Avg
81.33
5Y Avg
47.61
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MacroGenics, Inc. (MGNX) | $231.69M | N/A | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $233.62M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $231.25M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.62M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $234.90M | N/A | N/A | N/A | N/A |
| Utah Medical Products, Inc. (UTMD)vs › | $234.98M | 6.56 | 83.47 | 81.33 | 47.61 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.17M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $236.60M | N/A | N/A | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $225.88M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $228.27M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
